With over 100,000 users and operations spanning the globe, AstraZeneca faced a massive identity unification challenge shaped by regulatory complexity, legacy infrastructure, and technical fragmentation. They needed a modern, compliant, and scalable way forward – but solving it required more than just software. The answer would reshape how enterprise identity is approached in the life sciences space.